(Press-News.org)
November 19, 2024 - Tel Aviv Sourasky Medical Center, Tel Aviv, Israel – In a recent study, Tel Aviv Sourasky Medical Center has shed light on physician attitudes toward novel anti-amyloid treatments (ATT) for Alzheimer’s disease (AD), revealing a spectrum of opinions across key specialties. With Israel’s health system structured to provide universal healthcare, the high out-of-pocket costs for new AD therapies have raised questions among medical professionals about the feasibility and practicality of implementing these treatments.
The study, conducted by Dr. Noa Bregman and colleagues, is the first in Israel to examine how neurologists, geriatricians, and psychiatrists perceive the new ATT options as they are being introduced into clinical practice.
Key findings include:
Mixed Confidence in Treatment Efficacy: Over 60% of surveyed physicians expressed skepticism about ATT’s ability to significantly alter AD’s progression.
Specialty-Driven Differences in Referrals: Neurologists showed greater willingness to refer early-stage AD patients for ATT, while geriatricians and psychiatrists highlighted practical concerns, including costs, accessibility of biomarker tests, and the holistic management of elderly patients with comorbidities.
Influential Factors in Referrals: Physicians emphasized patient age, financial status, and access to specialized diagnostics as critical considerations when evaluating suitability for ATT.
Dr. Shir noted, "While these innovative treatments offer potential benefits, the findings highlight the importance of addressing the financial and logistical barriers that may hinder broader adoption. Our study underscores the need for multidisciplinary collaboration to ensure comprehensive patient care and to maximize the potential of ATT in Israel."
The research team suggests that initiatives aimed at education, cost-benefit analysis, and improved insurance coverage are essential to enhance ATT accessibility and physician confidence. Establishing specialized AD treatment centers could further support equitable access to these therapies.
This study, published in the Journal of Alzheimer's Disease (Volume 102, Issue 3), serves as an important step towards understanding and overcoming the challenges of implementing cutting-edge AD treatments. For further information on the study or to arrange an interview, please contact the Tel Aviv Sourasky Medical Center’s media relations team.
About Tel Aviv Sourasky Medical Center Tel Aviv Sourasky Medical Center is a leading healthcare provider in Israel, committed to excellence in medical care, research, and innovation. The Cognitive Neurology Unit is at the forefront of AD research and treatment, striving to improve patient outcomes and quality of life through advanced, patient-centered approaches.
About the Journal of Alzheimer’s Disease
The Journal of Alzheimer's Disease (JAD) is an international multidisciplinary journal to facilitate progress in understanding the etiology, pathogenesis, epidemiology, genetics, behavior, treatment, and psychology of Alzheimer's disease. The journal publishes research reports, reviews, short communications, book reviews, and letters-to-the-editor. Groundbreaking research that has appeared in the journal includes novel therapeutic targets, mechanisms of disease, and clinical trial outcomes. JAD has a Journal Impact Factor of 3.4 according to Journal Citation Reports™ (Clarivate, 2024). The journal is published by IOS Press, now part of Sage.
END
MINNEAPOLIS/ST. PAUL (11/19/2024) — Published in Child Psychiatry and Human Development, a research team led by the University of Minnesota Medical School found that Creativity Camp, a two-week arts intervention delivered as a day camp, had a positive impact on mental health and well-being in adolescents with depression.
The idea behind the study is that engaging in the arts offers a pathway for exploring and expanding new ways of thinking, developing insights and sparking self-discovery.
“As a clinician, I am deeply aware of the urgent need for new treatment options for teens with depression. The findings in this report are promising, and I hope they ...
Brain-imaging data collected from fetuses and infants has revealed a rapid surge in functional connectivity between brain regions on a global scale at birth, possibly reflecting neural processes that support the brain’s ability to adapt to the external world, according to a study published November 19th, in the open-access journal PLOS Biology led by Lanxin Ji and Moriah Thomason from the New York University School of Medicine, USA.
Understanding the sequence and timing of brain functional network ...
Des Plaines, IL — A new study that investigates low-dose ketamine (LDK) as an adjunct to morphine for treating acute pain has been published in the October issue of Academic Emergency Medicine (AEM), the peer-reviewed journal of the Society for Academic Emergency Medicine (SAEM).
The study, titled Low-dose ketamine as an adjunct to morphine: A randomized controlled trial among patients with and without current opioid use highlights the potential of low-dose ketamine as a valuable tool in pain management, providing a safe and effective option for emergency medicine physicians managing acute pain.
Pain remains one of the most common and challenging complaints ...
Research Highlights:
A clinical trial with adults who have atrial fibrillation (AFib) and an implanted heart device found similar improvements to the amount of time they experienced arrhythmia regardless of whether they received standard care (education pamphlets about healthy diet and exercise), followed a lifestyle/risk factor modification program, or took metformin and followed a lifestyle/risk factor modification program.
AFib burden, a measure of how much time a patient experiences atrial arrhythmia, improved during the treatment period — particularly in the standard of care and lifestyle risk factor modification groups.
Lifestyle and risk factor modification was associated ...
Cognitive neuroscientists in Trinity College Dublin have published new research describing a brand new approach to making habit change achievable and lasting.
This innovative framework has the potential to significantly improve approaches to personal development, as well as the clinical treatment of compulsive disorders (for example obsessive compulsive disorder, addiction, and eating disorders).
The research was led by Dr Eike Buabang, Postdoctoral Research Fellow in the lab of Professor Claire Gillan in the School of Psychology and has been published as a paper, Leveraging ...
Research Highlights:
The oral medication muvalaplin may safely lower high levels of lipoprotein(a), also known as Lp(a), an independent, inherited risk factor for cardiovascular disease.
Muvalaplin is a small molecule inhibitor that prevents the bonding of the two protein components that combine to make Lp(a). There are no currently FDA-approved medications to lower Lp(a) levels, though other medications are currently being evaluated in clinical trials. Muvalaplin is the first oral medication developed to lower Lp(a) levels.
Results ...
WEST LAFAYETTE, Ind. — Eradivir, a preclinical biotech company, has developed a patent-pending antiviral therapeutic that reduces lung viral loads of advanced-stage influenza in preclinical studies quicker and more effectively than currently available therapies.
A single intranasal dose of EV25, a bispecific small molecule developed by Eradivir, acts faster than the current standard of care, eliminating the detectable virus within 24 hours. EV25 also has a window of efficacy of 96 hours postinfection, which is broader than the current standard of care.
A ...
Every fall, millions of Medicare beneficiaries have the chance to pick a new stand-alone prescription drug plan that may be better suited for them, but most stick with the same plan.
A new study published today in Health Affairs Scholar suggests that 52% of Medicare beneficiaries with stand-alone Part D plans did not switch because they made no plan comparisons at all for 2024. Many of these beneficiaries (41%) also reported not knowing how to switch plans.
“Comparing these Medicare Part D plans is hard, so many beneficiaries just don’t do it. But beneficiaries who don’t compare plans may not notice if they are sticking with more expensive plans or ...
DALLAS, Nov. 19, 2024 —“What Would They Say?” – the powerful spoken word poem produced on video by the American Heart Association, which is celebrating 100 years of lifesaving service as the world’s leading voluntary organization focused on heart and brain health, has taken second place in the 4th Annual Anthem Awards winning the Silver Award in the Education, Art & Culture Campaign - Non-Profit Community Engagement category. This international recognition celebrates the Association’s impactful work and historic commitment ...
Even when their parents are lawyers, doctors, or executives, Black Britons are substantially more likely to end up in working class jobs than their White peers, a new study from the University of Kent reveals.
Funded by the Leverhulme Trust, this research shows that Black men from the most advantaged families are three times more likely than White men from similar backgrounds to be in working class jobs beyond age 30. Black women are also twice as likely as White women to experience this kind of downward mobility. This is true even after removing ...
